Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Rehabilitation and Physical Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
PM R. 2021 Aug;13(8):845-851. doi: 10.1002/pmrj.12475. Epub 2020 Oct 20.
To determine the feasibility and perception of usefulness of wearable trackers in inpatient and outpatient cancer rehabilitation patients.
Prospective study.
Acute inpatient rehabilitation and outpatient clinic at a tertiary cancer center.
Adult cancer patients (N = 100).
Participants were provided with wearable trackers for the duration of the study.
Survey regarding feasibility (as defined as equal or more than two-thirds of participants reporting use of the wearable tracker) and usefulness of the wearable tracker and Edmonton Symptom Assessment Scale (ESAS-FS) in both inpatient and outpatient populations. Activity minutes, number of steps, heart rate, and sleep data were collected from the wearable tracker.
Patients reported the use of a wearable tracker is feasible, with 48/50 (96%) outpatients and 47/50 (94%) inpatients reported wearing the wearable tracker daily and 37/49 (76%) outpatients and 29/50 (58%) inpatients reported that they would continue to wear the wearable tracker after this study. The majority of cancer patients (41/49 [84%] of outpatient and 33/50 [66%] of inpatient patients) reported that the wearable tracker was useful and 41/49 (84%) outpatients and 27/50 (54%) inpatients perceived the wearable tracker as helping to increase physical activity.
The use of wearable trackers in cancer patients is feasible and patients perceive wearable trackers as useful in both the inpatient and outpatient rehabilitation setting. Physical activity in these patients was better in the outpatient population, as expected because of less medical acuity.
确定可穿戴追踪器在住院和门诊癌症康复患者中的可行性和实用性。
前瞻性研究。
三级癌症中心的急性住院康复和门诊诊所。
成年癌症患者(N=100)。
在研究期间为参与者提供可穿戴追踪器。
调查可穿戴追踪器的可行性(定义为三分之二以上的参与者报告使用可穿戴追踪器)和实用性,以及在住院和门诊人群中埃德蒙顿症状评估量表(ESAS-FS)的实用性。从可穿戴追踪器中收集活动分钟数、步数、心率和睡眠数据。
患者报告可穿戴追踪器的使用是可行的,48/50(96%)名门诊患者和 47/50(94%)名住院患者每天佩戴可穿戴追踪器,37/49(76%)名门诊患者和 29/50(58%)名住院患者报告在这项研究后他们将继续佩戴可穿戴追踪器。大多数癌症患者(41/49[84%]名门诊患者和 33/50[66%]名住院患者)报告可穿戴追踪器有用,41/49(84%)名门诊患者和 27/50(54%)名住院患者认为可穿戴追踪器有助于增加身体活动。
可穿戴追踪器在癌症患者中的使用是可行的,患者在住院和门诊康复环境中都认为可穿戴追踪器有用。这些患者的身体活动在门诊人群中更好,这是预期的,因为医疗敏锐度较低。